References
- Segal R, Yaron M, Tartakovsky B. Methotrexate: mechanism of action in rheumatoid arthritis. Semin Arthritis Rheum 1990; 20: 190–9
- Perruquet J L, Harrington T M, Davis D E. Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis. Arthritis Rheum 1983; 26: 1291–2
- Leff R L, Case J P, McKenzie R. Rheumatoid arthritis, methotrexate therapy and Pneumocystis carinii pneumonia. Ann Intern Med 1990; 112: 716, (letter)
- Wollner A, Mohle-Boetani J, Lambert R A, Perruquet J L, Raffin T A, McGuire J L. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax 1991; 46: 205–7
- Flood D A, Chan C K, Pruzanski W. Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis. J Rheumatol 1991; 18: 1254–6
- Shiroky J B, Frost A, Skelton J D, Haegert D G, Newkirk M M, Neville C. Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 1991; 18: 1172–5
- Porter D R, Marshall D AS, Madhok R, Capell H, Sturrock R D. Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br J Rheumatol 1992; 31: 71–2
- Lang B, Riegel W, Peters T, Peter H-H. Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and Pneumocystis carinii pneumonia. J Rheumatol 1991; 18: 1257–9